In the present study, we showed that IOE treatment has similar effects to metformin to ameliorate insulin resistance, glucose intolerance, and dyslipidemia in mice, probably through activation of the insulin signaling pathway and upregulation of GLUT4 expression. The gene discussed is SLC2A4; the disease is Glucose intolerance.